Cologne, Germany

Romanis Fruchtmann


 

Average Co-Inventor Count = 5.9

ph-index = 7

Forward Citations = 189(Granted Patents)


Location History:

  • Koln, DE (1992 - 1995)
  • Cologne, DE (1986 - 1997)

Company Filing History:


Years Active: 1986-1997

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Innovations and Patents of Romanis Fruchtmann

Introduction

Romanis Fruchtmann, located in Cologne, Germany, is a distinguished inventor with an impressive portfolio of 24 patents. His work primarily focuses on compounds with potential applications in the medical field.

Latest Patents

Fruchtmann's recent innovations include two notable patents:

1. **Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives** - These compounds are synthesized by reacting correspondingly substituted phenols with quinolylmethyl halides or through the alkylation of unsubstituted phenols with quinolylmethyl halides. They show promise as active substances in medicaments.

2. **Quinolin-2-yl-methoxybenzylhydroxyureas** - Fruchtmann has developed these novel compounds by reacting specific ketones with hydroxylamine, followed by reducing the ketoximes and subsequent reaction with isocyanates. These substances also have potential as active ingredients in medical applications.

Career Highlights

Throughout his career, Romanis Fruchtmann has contributed significantly to the field of medicinal chemistry. He has worked with renowned companies such as Bayer Aktiengesellschaft and Troponwerke GmbH & Co. KG, where he has been instrumental in developing innovative solutions and products.

Collaborations

Fruchtmann has collaborated with fellow researchers and inventors, including Siegfried Raddatz and Christian Kohlsdorfer. These partnerships have enriched his work and further advanced his contributions to the industry.

Conclusion

Romanis Fruchtmann's extensive research and patent activity highlight his commitment to innovation in medicinal chemistry. His latest patents not only showcase his inventive capabilities but also underline the potential impact of his work on future medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…